Background: Vitamin D 3 , the most physiologically relevant form of vitamin D, is an essential organic compound that has been shown to have a crucial effect on the immune responses. Vitamin D 3 ameliorates the onset of the experimental autoimmune encephalomyelitis (EAE); however, the direct effect of vitamin D 3 on T cells is largely unknown.
Introduction

Interleukin (IL)-17-producing T cells have been identified in the mouse as a new lineage of CD4
+ T cells that can be differentiated from naïve T cells by the polarizing cytokines TGF-b, IL-6, and IL-23 [1] [2] [3] [4] . T H 17 cells can protect against bacterial pathogens by recruiting neutrophils but have also been reported to develop into an immunopathology in various models of autoimmunity [1] [2] [3] [4] .
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) characterized by inflammatory cell infiltration and subsequent demyelination of axonal tracts in the brain and spinal cord [5] . Demyelination disturbs the conduction of neuronal signals along axons, resulting in clinical symptoms including pain, fatigue, muscle weakness, and visual disturbances [5] . Several studies report that T H 17 cells are involved in the initiation and maintenance of experimental autoimmune encephalomyelitis (EAE), a murine model of MS [6, 7] . In addition, recent studies suggest that T H 17 cells (i.e., + T H 17 cells) have a high inflammatory potential and may constitute a relevant inflammatory subset in human MS [8, 9] . Some of these T H 17 cells secrete IFN-c (i.e., IFN-c + T H 17 cells), which preferentially migrates into the CNS in human MS [10, 11] .
Although the exact cause of MS remains unclear, genetic background and/or unknown environmental factors are believed to contribute to the onset of the disease. Epidemiological studies have shown that geographical location is associated with the incidence of MS, which increases with latitude in both hemispheres [12] . One potential explanation is that susceptibility to MS is related to exposure to sunlight and the subsequent production of vitamin D [13] . In one recent study, levels of vitamin D were significantly lower in relapsing-remitting patients than in healthy controls [14] . In addition, the level of vitamin D production in MS patients suffering a relapse was lower than in patients during remission [14] . Furthermore, vitamin D supplementation and higher levels of vitamin D in circulation are associated with a decreased incidence of MS [15, 16] .
Vitamin D is a well-known nutrient that acts as a modulator of calcium homeostasis and the immune response [17] , and the vitamin D receptor (VDR) is expressed in several types of immune cells, including monocytes, macrophages, dendritic cells (DCs), and effector/memory T cells [18] [19] [20] . In in vitro studies, 1,25(OH) 2 D 3 inhibits T cell proliferation, the production of IL-2 and IFN-c and cytotoxicity [21] [22] [23] . 1,25(OH) 2 D 3 negatively regulates the differentiation, maturation, and immunosti-mulatory capacity of DCs by decreasing the expression of MHC class II, CD40, CD80, and CD86 [24] [25] [26] . In addition, 1,25(OH) 2 D 3 decreases the synthesis of IL-6, IL-12, and IL-23 [27] [28] [29] . Hence it seems likely that 1,25(OH) 2 
Results
1,25(OH) 2 D 3 inhibits the onset of EAE and alters T H cell composition
To develop an animal experimental model of EAE, B6 mice were immunized subcutaneously with a peptide consisting of myelin oligodendrocyte glycoprotein (MOG ) in complete Freund's adjuvant (CFA) and pertussis toxin as described elsewhere [31] [32] [33] [34] . The severity of the resulting paralysis was determined as a disease score. Symptoms were shown at 9 days after challenge and high severity of paralysis was shown at about 20 days ( Figure 1A ). To confirm whether vitamin D 3 inhibits EAE initiation, mice were orally treated with 1,25(OH) 2 D 3 as described elsewhere [32] . Of note, most 1,25(OH) 2 D 3 -treated mice were completely resistant to the development of EAE ( Figure 1A ). Since previous studies demonstrated that autoreactive T cells, especially T H 1 and T H 17, are essential to induce EAE, we further analyzed T H cells in EAE-induced mice. To this end, mononuclear cells in the CNS (including the brain and spinal cord) were enriched by density gradient and analyzed by flow cytometry. As depicted in Figure 1B , significantly fewer infiltrated CD4 + T cells were present in the CNS of the 1,25(OH) 2 D 3 -treated EAE-induced mice than in the CNS of PBS-treated EAE-induced mice. We further analyzed the T H differentiation in the spleen and CNS of EAE-induced mice with and without oral 1,25(OH) 2 D 3 . As expected, IL-17-secreting T H 17 cells were predominant in the spleen of EAEinduced mice when compared with the untreated wild-type B6 mice ( Figure 1C ). Of note, oral treatment with 1,25(OH) 2 D 3 dramatically reduced the numbers of T H 17 cells in the spleen of EAE-induced mice ( Figure 1C , p = 0.00114). In addition, increased numbers of T H 17 cells were detected in the CNS of EAE-induced mice ( Figure 1C) The biological actions of vitamin D 3 are mediated through the VDR, a member of the nuclear receptor superfamily [36] . To investigate whether VDR is essential for vitamin D 3 to regulate T H cell differentiation, we used VDR 2/2 mice. As expected, deficiency of the VDR did not influence Treg and T H 17 differentiation ( Figure 4A and B). Of note, CD4
+ T cells isolated from VDR 2/2 mice were resistant to the inhibitory effect of vitamin D 3 on the differentiation of Treg ( Figure 4A ) and T H 17 ( Figure 4B ) under polarizing conditions. In contrast, the inhibitory role of 1,25(OH) 2 D 3 on Treg and T H 17 differentiation was still shown when VDR 2/2 APCs were adopted ( Figure 4A and B). Therefore, the VDR signal on activated CD4 + T cells was essential to down-regulate the development of Treg and T H 17 cells.
Down-regulation of Treg differentiation by 1,25(OH) 2 D 3 is dependent on the low production of IL-2
Since vitamin D 3 inhibits the secretion of IL-2, which is essential for the generation of Treg cells [37, 38] , we first measured IL-2 levels in the culture supernatant after stimulation with vitamin D 3 . Interestingly, co-culture with vitamin D 3 decreased IL-2 production by CD4
+ T cells in a dose-dependent manner ( Figure 5A ). To investigate whether IL-2 recovers from the decrease of Treg differentiation caused by 1,25(OH) 2 
Regulation of T H 17 differentiation by vitamin D 3 is independent of IL-10
Since a previous study showed that IL-10 plays a crucial role in the vitamin D 3 -mediated inhibition of EAE [32] , we further assessed the role of IL-10 on the inhibition of IL-17 production by 1,25(OH) 2 Previous studies reported that IL-27 was up-regulated in APCs isolated from the CNS and lymph nodes of EAE-induced mice [39] . In addition, a combination of IL-27 and TGF-b has been shown to promote the differentiation of IL-10-producing Tr-1 cells [34, 40] . Therefore, it is possible that vitamin D 3 The mechanism of suppression of T H 17 generation by 1,25(OH) 2 D 3 is independent on STAT1 Since the effect of vitamin D 3 is similar to that of IL-27, which inhibits the development of T H 17 cells through STAT1-dependent mechanisms [41] [42] [43] , we adopted STAT1 2/2 mice to help us address the role that STAT1 signaling has on vitamin D3's inhibitory effect on T H 17 differentiation. As expected, IL-27 failed to inhibit T H 17 development in STAT1 2/2 T cells under T H 17-polarizing conditions (Figure 7 ). However, under T H 17-polarizing conditions, 1,25(OH) 2 D 3 suppressed IL-17 expression in both STAT1 2/2 and STAT1 +/+ CD4 + T cells ( Figure 7 ). These results indicate that the negative regulation of T H 17 by vitamin D 3 is independent on STAT1.
1,25(OH) 2 D 3 negatively regulates the expression and migration of CCR6
+ T cells
A recent study reported that the CCR6-CCL20 axis plays an essential role in controlling the entry of T H 17 cells into the CNS and thus mediates the initiation of EAE [44] . In our present study, we found significantly reduced migration of CD4 + T cells into the 
Discussion
In this study, we found that oral administration with 1,25(OH) 2 A previous study demonstrated that Smad3, signal transducers of the TGF-b superfamily, mediated cross-talk between TGF-b and vitamin D 3 signaling pathways [52] . The cooperative actions of the Smad3-VDR complex can be synergistic or antagonistic in a conditional manner [53] . In addition, another study suggested that conditions (rTGF-b, 1 ng/ml; rIL-6, 20 ng/ml; anti-IFN-c, 10 mg/ml; and anti-IL-4, 10 mg/ml). the enhancement of TGF-b-driven Smad3 signaling by retinoic acid increases the number of Foxp3-expressing T cells and inhibits the development of T H 17 cells [54] . These several lines of study lead us to speculate that Smad3 mediates vitamin D 3 's ability to inhibit the development of T H 17 cells. However, as of yet we have not been able to verify this hypothesis.
Another study reported that the combination of vitamin D 3 and dexamethasone increased the frequency at which IL-10-producing regulatory T cells are generated [55] . Further, vitamin D 3 failed to inhibit EAE in IL-10 2/2 or IL-10R 2/2 B6 mice [32] . However, in our in vitro study, vitamin D 3 alone failed to induce IL-10 production in activated T cells ( Figure 6A and B) . Thus, it requires additional factors to protect against EAE through the IL-10 effect. Vitamin D 3 helped TGF-b mediate IL-10 production and strongly enhanced the generation of IL-27-mediated IL-10-producing CD4 + T cells in an in vitro system ( Figure 6E) . A recent study clearly showed that IL-27 plays a crucial role in the development of IL-10-producing anti-inflammatory T cells [40] . Others reported that IL-27 and IL-27R are up-regulated in APCs from the CNS and lymph nodes in EAE-induced mice [39] . When considered together, the facts that IL-27 is a good inducer of IL-10-producing T cells and that 1,25(OH) 2 D 3 possesses synergistic effects under T H 17-polarizing conditions suggest that vitamin D 3 requires the presence of TGF-b and IL-6 to increase the number of IL-27-mediated IL-10-producing T cells. Thus, it is possible that vitamin D 3 cooperates with IL-27 to protect against EAE through IL-10.
A recent study found that CCR6 plays an essential role in the initiation of EAE and that CCL20, a CCR6 ligand, is constitutively expressed in choroid plexus epithelial cells in mice and humans [44] . Further, T H 17 cells predominantly express CCR6 [56] . In accordance, it has been suggested that the recruitment of T H 17 cells via the CCR6-CCL20 axis is necessary for development of T H 17 cell-mediated autoimmune disease. As depicted in Figure 1B , CD4 + T cells were highly infiltrated in EAE-induced mice whereas 1,25(OH) 2 D 3 -treated mice had extremely low numbers of CD4 + T cells in their CNS. However, although CCR6 are important for recruitment of T H 17 cells into 
Materials and Methods
Mice
Female BALB/c and C57BL/6 mice (Charles River Laboratories, Seoul, Korea) were used at ages 8-12 wks. Rag2 2/2 DO11.10 mice (BALB/c background), MOG-TCR (2D2) transgenic mice (B6 background), IL-10 2/2 mice (B6 background), and STAT1 2/2 (B6 background) were purchased from Taconic (Germantown, NY) and Jackson Laboratory (Bar Harbor, ME). VDR 2/2 mice were kindly provided by Prof. S. Kato (University of Tokyo, Tokyo, Japan). All mice were maintained under pathogen-free conditions in the experimental facility at the International Vaccine Institute (Seoul, Korea) where they received sterilized food and water ad libitum and all experiments described in this article were approved by Institutional Animal Care and Use Committees (Approval No: PN 0901).
Vitamin D 3 treatment and induction of EAE
One mg/ml stock of 1,25(OH) 2 D 3 (Sigma-Aldrich, St. Louis, MO) in DMSO was added to water (50 ng/day for females; 100 ng/day for males). Alternatively, 200 ng of 1,25(OH) 2 D 3 in oil or oil only as a placebo was injected i.p. [32] . To induce EAE, myelin oligodendrocyte glycoprotein peptide (MOG , MEVG-WYRSPFSRVVHLY-RNGK) was resuspended in sterile PBS to a concentration of 4 mg/ml and then emulsified with an equivalent volume of complete Freund's adjuvant (CFA) supplemented with 5 mg/ml Myocobacterium tuberculosis H37Ra (BD Diagnostic Systems, Sparks, MD). EAE was induced in 9-to 10-wk old female C57BL/6 mice by s.c. injection of 100 ml of MOG /CFA homogenate delivering 200 mg of MOG peptide. On days 1 and 3 after immunization, the mice were injected i.p. with 200 ng of pertussis toxin (Sigma-Aldrich) diluted in PBS. The mice were then scored daily for clinical signs of EAE using the following scale for a ''disease score'': 0 = no clinical disease, 1 = loss of tail tone, 2 = unsteady gait, 3 = hind limb paralysis, 4 = forelimb paralysis, 5 = death.
In vitro T H generation
All experiments were performed with highly purified CD4 + CD25 2 naïve T cells (.95% purity). To purify naïve T cells, erythrocyte-depleted splenocytes were first depleted of CD25 + cells via magnetic selection using anti-CD25 microbeads (Miltenyi Biotec, Auburn, CA). In the remaining population, CD4
+ cells were positively selected using anti-CD4 microbeads (Miltenyi Biotec). Cells were cultured in complete RPMI 1640 supplemented with 10% FBS and 50 U/ml of penicillin and streptomycin. For antigen-specific stimulation, purified CD4 + T cells from MOG TCR-Tg or Rag2 2/2 DO11.10 mice were incubated with MOG (25 mg/ml) or OVA 323-339 (0.2 mM) peptide presented by CD3-depleted splenocytes under Tregpolarizing conditions (1 ng/ml rhTGF-b1, 10 mg/ml anti-IFN-c, and 10 mg/ml anti-IL-4); under T H 17-polarizing conditions (1 ng/ ml rhTGF-b1, 20 ng/ml rmIL-6, 10 mg/ml anti-IFN-c, and 10 mg/ml anti-IL-4); or under T H 1-polarizing conditions (4 ng/ ml rmIL-12 and 10 mg/ml anti-IL-4). Death cells were confirmed by propidium iodide (PI; BD Pharmingen, San Diego, CA) staining and were excluded before analysis.
Flow-cytometric analyses
CD4
+ T cells were collected and stimulated with PMA (50 ng/ ml; Sigma-Aldrich) and ionomycin (750 ng/ml; Calbiochem, La Jolla, CA) for 5 hr in the presence of Golgi Plug (BD Pharmingen). Anti-mouse CD3e-PerCP (145-2C11; BioLegend, San Diego, CA), anti-mouse CD4-FITC (RM4-5; BD Pharmingen), anti-mouse DO-11.10 Clonotypic TCR (KJ1-26; BD Pharmingen), antimouse TCR Va3.2-FITC (RR3-16; BD Pharmingen), anti-mouse TCR Vb 11 PE (RR3-15; BD Pharmingen), anti-mouse IL-17A-APC (eBio17B7; eBioscience, San Diego, CA), anti-mouse IFN-c-APC (XMG1.2; BD Pharmingen), anti-mouse Foxp3-APC (FJK16s; eBioscience), and anti-mouse IL-10-PE Abs (JES5-16E3; BD Pharmingen) were used according to manufacturers' instructions. Data were obtained using a FACSCalibur (BD Immunocytometry Systems, San Jose, CA) with CellQuest software and the profiles were analyzed using Flowjo flow cytometry software (TreeStar Inc., Ashland, OR).
Real-time PCR and RT-PCR
To assess the expression of IL-17 and Foxp3, mRNA was extracted using TRIzol (Invitrogen, Camarillo, CA) according to the manufacturer's instructions and then reverse transcribed into cDNA. The primer sequences for amplification of each transcript are as follows: IL-17, 59-GGTCAACCTCAAAGTCTTTAAC-TC-39 and 59-TTAAAAAT GCAAGTAA GTTTGCTG-39; Foxp3, 59-CAGCTGCCTACAGTGCCCCTAG-39 and 59-CA-TTTGC CAGCAGTGGGTAG-39; b-actin, 59-ATCTGGCAC-CACACCTTCTACAATGAGCT GCG-39 and 59-CGTCATA-CTCCTGCTTGCTGATCCACAT CTGC-39.
Chemotaxis assay
To evaluate the migration of T H 17 cells, 5-mm Transwell inserts (Corning, Cambridge, MA) containing 1610 5 in vitro-generated T H 17 cells were placed in the 24-well plate so as to make contact with 600 ml of the medium alone (basal) or with 100 nM MIP-3a/ CCL20 (R&D Systems, Minneapolis, MN). Two hours later, the inserts were removed and the population that migrated to the well bottoms was counted.
Statistics
Data are expressed as the mean 6 SD. Statistical comparisons between experimental groups were performed using the Student ttest.
